A Retrospective Study to Understand the Clinical Management of Subjects With Multiple Sclerosis at a Site in Taiwan Over the Last 10 Years
NCT01084798 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 123
Last updated 2014-07-31
Summary
This is an observational, non comparative, non-randomised, open-label, retrospective, single centre study planned to collect the data of subjects diagnosed with multiple sclerosis (MS) as per Poser or McDonald criteria between 1997 and 2007 in Taiwan. The clinical features and annual relapse rate in the first five years after the onset of disease have been compared between conventional and optico-spinal MS in the earlier studies. This study aims to understand the clinical care pathway of MS subjects and facilitate the subject's diagnosis before converting to MS.
Conditions
Sponsors & Collaborators
-
Merck KGaA, Darmstadt, Germany
lead INDUSTRY
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-08-31
- Primary Completion
- 2008-12-31
- Completion
- 2009-11-30
Countries
- Taiwan
Study Locations
More Related Trials
-
Understanding Magnetic Resonance Imaging in Multiple Sclerosis
NCT03872583 ·Status: COMPLETED ·Phase: NA
-
Characterization of Early Patients Initiating Ofatumumab for Treatment of Multiple Sclerosis.
NCT05576779 ·Status: COMPLETED
-
Safety and Efficacy Study of Fingolimod in Taiwanese Adults (≥ 20years) With Relapsing Remitting Multiple Sclerosis
NCT04480853 ·Status: RECRUITING ·Phase: PHASE4
-
POC-MD MRI-based Trial in Relapsing-remitting Multiple Scler
NCT01051817 ·Status: COMPLETED ·Phase: PHASE2
-
To Study the Pathophysiological Features of Multiple Sclerosis
NCT04242056 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
A Study to Assess the Effects of MK0812 on Disease Activity in Patients With Relapsing-Remitting Multiple Sclerosis as Measured by Magnetic Resonance Imaging (MRI)(0812-003)(COMPLETED)
NCT00239655 ·Status: TERMINATED ·Phase: PHASE2
-
Characteristic Study on Chinese Patients With Multiple Sclerosis
NCT00818103 ·Status: UNKNOWN ·Phase: NA
-
A Canadian Study Assessing the Utility of the Treatment Optimization Recommendations in Multiple Sclerosis
NCT01142583 ·Status: COMPLETED
-
Efficacy and Safety of MBP8298 in Subjects With Secondary Progressive Multiple Sclerosis
NCT00468611 ·Status: TERMINATED ·Phase: PHASE3
-
Multiple Sclerosis Versus Neuromyelitis Optica Spectrum Disorder
NCT07304960 ·Status: NOT_YET_RECRUITING
-
Advanced MRI Sequences in Multiple Sclerosis and Its Mimics
NCT03608605 ·Status: UNKNOWN
-
The MS-LINK™ Outcomes Study
NCT04735406 ·Status: COMPLETED
-
A Study of Multiple Sclerosis Routine Clinical Practice: Impact on Adherence and Clinical Outcomes of Ofatumumab Treated Patients
NCT06897657 ·Status: COMPLETED
-
Masitinib in the Treatment of Patients With Primary Progressive or Non-active Secondary Progressive Multiple Sclerosis
NCT05441488 ·Status: SUSPENDED ·Phase: PHASE3
-
Use of a Smartphone Application to Predict the Prognosis in Patients With Newly Diagnosed Multiple Sclerosis.
NCT04595799 ·Status: ACTIVE_NOT_RECRUITING
-
A Study of the Safety and Efficacy of ONO-4641 in Patients With Relapsing-Remitting Multiple Sclerosis
NCT01081782 ·Status: COMPLETED ·Phase: PHASE2
-
An Observational Biomarker Study in Multiple Sclerosis (MS) Patients
NCT05663853 ·Status: COMPLETED
-
A Study of Ocrelizumab in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) Who Have Had a Suboptimal Response to an Adequate Course of Disease-Modifying Treatment (DMT)
NCT02861014 ·Status: COMPLETED ·Phase: PHASE3
-
Prescription Drug Safety and Effectiveness in Multiple Sclerosis
NCT04472975 ·Status: COMPLETED
-
Observational Study in Multiple Sclerosis Patients Treated With Autologous Hematopoietic Stem Cell Transplantation
NCT04674280 ·Status: UNKNOWN
-
Measuring Silent Disease Progression in Multiple Sclerosis With a Multimodal Approach
NCT06501950 ·Status: RECRUITING
-
Evaluation of Sloan-Charts for Assessment of Disease Progress in Multiple Sclerosis
NCT01272596 ·Status: COMPLETED
-
Optical Coherence Tomography (OCT) Trial in Multiple Sclerosis
NCT02907281 ·Status: COMPLETED
-
Evaluation of Clinical, Morphologic and Biochemical Markers in Multiple Sclerosis
NCT04892134 ·Status: RECRUITING
-
DTI in Children With Multiple Sclerosis
NCT02361697 ·Status: UNKNOWN ·Phase: NA